Artigos com autorizações de acesso público - Maryam Lustberg MD MPH FASCOSaiba mais
3 artigos não disponíveis publicamente
Sensorimotor cortical thickness changes following taxane-based chemotherapy: support for a CNS role in CIPN?
L Worthen-Chaudhari, S Monfort, A Chaudhari, M Lustberg
Archives of Physical Medicine and Rehabilitation 104 (3), e51, 2023
Autorizações: US National Science Foundation, US National Institutes of Health
Case study in chemotherapy-induced neuropathy: tango dance improved over-ground local gait stability
N Glover, J WIlder, M Hackney, M Lustberg, L Worthen-Chaudhari
Archives of Physical Medicine and Rehabilitation 104 (3), e16, 2023
Autorizações: US National Institutes of Health
Biomechanical Effect of Music and Dance on Postural Control Among Breast Cancer Survivors With Neuropathy
L Worthen-Chaudhari, C Bland, J WIlder, R Wali, A Bibi, S Taha, ...
Archives of Physical Medicine and Rehabilitation 104 (3), e14-e15, 2023
Autorizações: US National Institutes of Health
173 artigos disponíveis publicamente
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
Autorizações: US National Institutes of Health, Fonds de recherche du Québec - Santé
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline
DL Hershman, C Lacchetti, RH Dworkin, EM Lavoie Smith, J Bleeker, ...
Journal of clinical oncology 32 (18), 1941-1967, 2014
Autorizações: US National Institutes of Health
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update
CL Loprinzi, C Lacchetti, J Bleeker, G Cavaletti, C Chauhan, DL Hertz, ...
Journal of Clinical Oncology 38 (28), 3325-3348, 2020
Autorizações: US National Institutes of Health
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ...
Annals of oncology 32 (6), 787-800, 2021
Autorizações: US National Institutes of Health, Fonds de recherche du Québec - Santé
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update
J Bohlius, K Bohlke, R Castelli, B Djulbegovic, MB Lustberg, M Martino, ...
Blood advances 3 (8), 1197-1210, 2019
Autorizações: US National Institutes of Health
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
Autorizações: US National Institutes of Health, US Assistant Secretary for Preparedness …
Triple-negative breast cancer: promising prognostic biomarkers currently in development
J Sukumar, K Gast, D Quiroga, M Lustberg, N Williams
Expert review of anticancer therapy 21 (2), 135-148, 2021
Autorizações: US National Institutes of Health
Management of neutropenia in cancer patients
MB Lustberg
Clinical advances in hematology & oncology: H&O 10 (12), 825, 2012
Autorizações: US National Institutes of Health
Platinum‐induced peripheral neurotoxicity: from pathogenesis to treatment
NP Staff, G Cavaletti, B Islam, M Lustberg, D Psimaras, S Tamburin
Journal of the Peripheral Nervous System 24, S26-S39, 2019
Autorizações: US National Institutes of Health
Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells
JP Oliveira-Costa, AF de Carvalho, GG da Silveira, P Amaya, Y Wu, ...
Oncotarget 6 (25), 20902, 2015
Autorizações: US National Institutes of Health
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
MB Lustberg, P Balasubramanian, B Miller, A Garcia-Villa, C Deighan, ...
Breast Cancer Research 16, 1-15, 2014
Autorizações: US National Institutes of Health
Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis
A Guha, MG Fradley, SF Dent, NL Weintraub, MB Lustberg, A Alonso, ...
European heart journal 43 (4), 300-312, 2022
Autorizações: US National Institutes of Health, American Heart Association, Robert Wood …
Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck
P Balasubramanian, JC Lang, KR Jatana, B Miller, E Ozer, M Old, ...
Public Library of Science 7 (7), e42048, 2012
Autorizações: US National Institutes of Health
Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients
SM Monfort, X Pan, R Patrick, B Ramaswamy, R Wesolowski, ...
Breast cancer research and treatment 164, 69-77, 2017
Autorizações: US National Science Foundation, US National Institutes of Health
Breast cancer and social environment: getting by with a little help from our friends
A Hinzey, MM Gaudier-Diaz, MB Lustberg, AC DeVries
Breast Cancer Research 18, 1-9, 2016
Autorizações: US National Institutes of Health
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
MB Lustberg, NM Kuderer, A Desai, C Bergerot, GH Lyman
Nature Reviews Clinical Oncology 20 (8), 527-542, 2023
Autorizações: US National Institutes of Health
Estrogen receptor beta (ERβ): a ligand activated tumor suppressor
R Mal, A Magner, J David, J Datta, M Vallabhaneni, M Kassem, ...
Frontiers in oncology 10, 587386, 2020
Autorizações: US National Institutes of Health
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador